Featured News Image news | May 16 2024 Wu Tsai Neurosciences Institute How we remember, why we forget This week on From Our Neurons to Yours, we talk with memory expert Anthony Wagner about the nature of memory and how to improve it Image news | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter our perceptions? (Part ... This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain. How do tiny quantities of these chemicals alter our perception of reality? And what does that say about... reality? Image news | May 7 2024 Wu Tsai Neuro Exploring MRI's role in neuroscience research on model organisms Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants. Image news | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine News Filter & Sort Sort by Theme (-) NeuroHealth News TypeFeatured News Research news Podcast episodes Awards and honors Sort by Newest to oldest Oldest to newest Image news | May 11 2023 From Our Neurons to Yours Brain Fog In this episode, neuroscientist and pediatric oncologist Michelle Monje helps us understand the mystery of the persistent "brain fog" that often plagues Long COVID patients. Image news | Oct 20 2021 Stanford Medicine Michelle Monje elected to National Academy of Medicine Wu Tsai Neuro faculty affiliate Michelle Monje, MD, PhD, was one of four Stanford Medicine faculty members elected to the prestigious National Academy of Medicine in 2021. Image news | Dec 6 2018 Stanford Medicine - News Center ‘Chemo brain’ caused by malfunction in three types of brain cells Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.
Image news | May 16 2024 Wu Tsai Neurosciences Institute How we remember, why we forget This week on From Our Neurons to Yours, we talk with memory expert Anthony Wagner about the nature of memory and how to improve it
Image news | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter our perceptions? (Part ... This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain. How do tiny quantities of these chemicals alter our perception of reality? And what does that say about... reality?
Image news | May 7 2024 Wu Tsai Neuro Exploring MRI's role in neuroscience research on model organisms Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants.
Image news | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine
Image news | May 11 2023 From Our Neurons to Yours Brain Fog In this episode, neuroscientist and pediatric oncologist Michelle Monje helps us understand the mystery of the persistent "brain fog" that often plagues Long COVID patients.
Image news | Oct 20 2021 Stanford Medicine Michelle Monje elected to National Academy of Medicine Wu Tsai Neuro faculty affiliate Michelle Monje, MD, PhD, was one of four Stanford Medicine faculty members elected to the prestigious National Academy of Medicine in 2021.
Image news | Dec 6 2018 Stanford Medicine - News Center ‘Chemo brain’ caused by malfunction in three types of brain cells Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.